We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

65 hedge funds and large institutions have $183M invested in ChemoCentryx, Inc. in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,021% more call options, than puts

Call options by funds: $2.89M | Put options by funds: $258K

49% more capital invested

Capital invested by funds: $123M → $183M (+$60M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 64 → 65 (+1)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
65
Holders Change
+1
Holders Change %
+1.56%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
20
Reduced
19
Closed
8
Calls
$2.89M
Puts
$258K
Net Calls
+$2.63M
Net Calls Change
+$2.25M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.11M
2
Millennium Management
Millennium Management
New York
+$1.95M
3
First Manhattan
First Manhattan
New York
+$1.38M
4
Goldman Sachs
Goldman Sachs
New York
+$776K
5
BACM
Blue Arrow Capital Management
New York
+$740K

Top Sellers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.04M
2
BC
Broadfin Capital
New York
-$3.6M
3
GPP
Great Point Partners
Connecticut
-$2.18M
4
Franklin Resources
Franklin Resources
California
-$532K
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$476K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$58.7M – – –
Capital World Investors
2
Capital World Investors
California
$23.7M +$214K +40,440 +1%
WA
3
Wasatch Advisors
Utah
$17.3M -$32.3K -6,106 -0.2%
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$12.4M -$5.04M -953,771 -35%
Franklin Resources
5
Franklin Resources
California
$11.8M -$532K -100,688 -6%
Westfield Capital Management
6
Westfield Capital Management
Massachusetts
$8.72M -$476K -89,960 -7%
BFA
7
BlackRock Fund Advisors
California
$8.66M +$418K +79,125 +7%
Vanguard Group
8
Vanguard Group
Pennsylvania
$5.65M +$273K +51,605 +7%
GCM
9
Gruss Capital Management
New York
$3.3M +$282K +53,408 +12%
AG
10
Artal Group
Luxembourg
$2.73M +$661K +125,000 +45%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$2.73M +$2.11M +399,200 New
Millennium Management
12
Millennium Management
New York
$2.7M +$1.95M +368,597 +1,396%
State Street
13
State Street
Massachusetts
$2.56M +$131K +24,837 +7%
First Manhattan
14
First Manhattan
New York
$1.78M +$1.38M +260,500 New
Northern Trust
15
Northern Trust
Illinois
$1.73M -$97.3K -18,408 -7%
BIT
16
BlackRock Institutional Trust
California
$1.6M -$53.1K -10,041 -4%
PI
17
Putnam Investments
Massachusetts
$1.37M – – –
Goldman Sachs
18
Goldman Sachs
New York
$1M +$776K +146,834 New
BACM
19
Blue Arrow Capital Management
New York
$956K +$740K +140,000 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$881K +$11.9K +2,256 +2%
TCIM
21
TIAA CREF Investment Management
New York
$848K +$35.8K +6,771 +6%
BCM
22
Bridgeway Capital Management
Texas
$820K – – –
Bank of New York Mellon
23
Bank of New York Mellon
New York
$751K -$6.16K -1,164 -1%
Barclays
24
Barclays
United Kingdom
$717K +$507K +95,874 +407%
JP Morgan Chase
25
JP Morgan Chase
New York
$703K -$85.8K -16,222 -14%
1
2 3

CCXI Hedge Fund Activity: Q4 2014 in Review

65 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2014, worth a combined $183M — up 49% from $123M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CCXI positions and 8 closed out — a net gain of 3 holders — while 20 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $2.11M. The largest seller was Balyasny Asset Management, cutting an estimated $5.04M.

  • 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2014, up from 64 in Q3 2014.
  • Funds reported $183M of ChemoCentryx, Inc. stock for Q4 2014, up 49% quarter-over-quarter.
  • 11 funds opened new ChemoCentryx, Inc. positions in Q4 2014 and 8 closed out, a net change of +3 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2014 was Fidelity Investments, an estimated $2.11M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2014 was Balyasny Asset Management, an estimated $5.04M sold.

Based on aggregated 13F filings for Q4 2014.